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Supportive Information
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Table S1.  Overview of milk protein N- and O-glycosylation research.
Glycoprotein Authors Title article Journal
Lactoferrin Matsumoto, A., 
et al.
Structural study of the sugar chains of human lactoferrin: finding of four novel 
complex-type asparagine-linked sugar chains
J. Biochem. 1982, 91, 143-
155
Spik, G., et al. Primary structure of the glycans from human lactotransferrin Eur. J. Biochem. 1982, 121, 
413-419
Montreuil, J., et 
al.
Transferrin superfamily – An outstanding model for studying biochemical 
evolution
New Compr. Biochem. 
1997, 29b, 203-242
Yu, T., et al. Comprehensive characterization of the site-specific N-glycosylation of wild-
type and recombinant human lactoferrin expressed in the milk of transgenic 
cloned cattle




Heterogeneity of bovine lactotransferrin glycans. Characterization of a-D-
Galp-(1→3)-b-D-Gal- and a-NeuAc-(2→6)-b-D-GalpNAc-(1→4)-b-D-
GlcNAc-substituted N-linked glycans
Carbohydr. Res. 1992, 236, 
145-164
Van Leeuwen, S. 
S., et al.
Use of Wisteria floribundi agglutinin affinity chromatography in the structural 
analysis of the bovine lactoferrin N-linked glycosylation
Biochim. Biophys. Acta 
2012, 1820, 1444-1455
κ-casein Van Halbeek, H., 
et al.
Isolation and structural characterization of the smaller-size oligosaccharides 
from desialylated human k-casein – Establishment of a novel type of core for a 
mucin-type carbohydrate chain
FEBS Lett. 1985, 187, 
81-88
Saito, T., et al. Chemical structure of neutral sugar chains isolated from human mature milk 
k-casein




Cow k-casein: Structure of the carbohydrate portion Biochim. Biophys. Acta 
1979, 576, 339-346
Van Halbeek, H., 
et al.
A 360-MHz 1H-NMR study of three oligosaccharides isolated from cow k-
casein
Biochim. Biophys. Acta 
1980, 623, 295-300
Van Halbeek, H., 
et al.
Structural characterization of a novel acidic oligosaccharide unit derived from 
cow colostrum k-casein – A 500 MHz 1H-NMR study
FEBS Lett. 1981, 133, 
45-50
Saito, T., et al. The chemical structure of a tetrasaccharide containing N-acetylglucosamine 
obtained from bovine colostrum κ-casein
Biochim. Biophys. Acta 
1981, 673, 487-494
Saito, T., et al. The chemical structure of neutral and acidic sugar chains obtained from bovine 
colostrum κ-casein
Biochim. Biophys. Acta 
1981, 678, 257-267
Saito, T., et al. A new hexasaccharide chain isolated from bovine colostrum κ-casein taken at 
the time of parturition
Biochim. Biophys. Acta 
1982, 719, 309-317
Fiat, A.-M., et al. Structural variability of the neutral carbohydrate moiety of cow colostrum 
k-casein as a function of time after parturition – Identification of a tetrasaccha-
ride with blood group I specificity
Eur. J. Biochem. 1988, 173, 
253-259
Ig’s Mizoguchi, A., 
et al.
Structures of the carbohydrate moieties of secretory component purified from 
human milk




Structure des glycannes des immunoglobulines sIgA du lait de femme Le Lait 1982, 62, 409-414
Pierce-Cretel, A., 
et al.
Primary structure of the N-glycosidically linked sialoglycans of secretory im-
munoglobulins A from human milk




Heterogeneity of the glycans O-glycosidically linked to the hinge region of 
secretory immunoglobulins from human milk
Eur. J. Biochem. 1981, 114, 
169-178
Aoki, N., et al. A bovine IgG heavy chain contains N-acetylgalactosaminylated N-linked sugar 
chains
Biochem. Biophys. Res. 
Commun. 1995, 210, 275-
280
MFGM Wilson, N. L., 
et al.
Glycoproteomics of milk: differences in sugar epitopes on human and bovine 
milk fat globule membranes




Isolation and structural characterization of alkali-labile oligosaccharides from 
bovine milk-fat-globule membrane
Biochem. J. 1978, 171, 
549-557
Sato, T., et al. Most bovine milk fat globule membrane glycoproteins contain asparagine-
linked sugar chains with GalNAcβ1®4GlcNAc groups
J. Biochem. 1993, 114, 
890-900
GalT Endo, T., et al. Structure identification of the complex-type asparagine-linked sugar chains of 
b-D-galactosyltransferase purified from human milk
Carbohydr. Res. 1986, 150, 
241-263.
Amano, J., et al. Structures of mucin-type sugar chains of the galactosyltransferase purified 
from human milk – Occurrence of the ABO and Lewis blood group determi-
nants
J. Biol. Chem. 1991, 266, 
11461-11477
Mucin Hanisch, F.-G., 
et al.
Structures of neutral O-linked polylactosaminoglycans on human skim milk 
mucins – A novel type of linearly extended poly-N-acetyllactosamine back-
bones with Galb(1-4)GlcNAcb(1-6) repeating units
J. Biol. Chem. 1989, 264, 
872-883
Pallesen, L. T., 
et al.
Characterization of carbohydrate structures of bovine MUC15 and distribution 
of the mucin in bovine milk
J. Dairy Sci. 2007,. 90, 
3143-3152
Lipase Landberg, E., 
et al.
Changes in glycosylation of human bile-salt-stimulated lipase during lactation Arch. Biochem. Biophys. 
2000, 377, 246-254
Lactophorin Inagaki, M., 
et al.
The multiplicity of N-glycan structures of bovine milk 18 kDa lactophorin 
(Milk GlyCAM-1)
Biosc. Biotechnol. Biochem. 
2010, 74, 447-450
PP3 Girardet, J.-M., 
et al.
Structure of glycopeptides isolated from bovine milk component PP3 Eur. J. Biochem. 1995, 234, 
939-946
α-Lactalbumin Tilley, C. A., 
et al.
The major oligosaccharide of bovine a-lactalbumin carries terminal b-linked 
GalNAc
Glycoconj. J. 1991, 8, 
249-250
Table S2.  N-Glycan structures observed in WFA-fraction I and after sequential exoglycosidase treatments. For each non-
sialylated assigned NP-HPLC peak (percentages for each profile A-F are based on HPLC peak integrations), MALDI-
TOF-MS confirmation was acquireda. 
Structure m/z GU Ab B C D E F
ndc 11.02 2 2 0 0 0 0
nd 10.67 2 2 0 0 0 0
nd 10.61 1 1 0 0 0 0
nd 10.32 1 1 0 0 0 0
nd 9.82 5 5 0 0 0 0
nd 9.54 6 6 0 0 0 0
nd 9.96 1 1 0 0 0 0
nd 9.47 2 2 0 0 0 0
nd 9.12 <1 <1 0 0 0 0
nd 8.34 13 13 0 0 0 0
nd 7.10 nod 5 0 0 0 0
nd 6.84 no 4 0 0 0 0
2660.2 9.76 1 <1 2 0 0 0
2514.1 9.56 1 <1 3 5 0 0
2295.6 8.75 1 1 7 0 0 0
2149.5 8.43 2 2 7 14 0 0
2025.7 9.45 5 0 0 0 0 0
1945.8 7.98/8.06 no no <1 <1 0 0
1929.7 7.70 7 8 18 0 0 0
1865.7 6.72 0 0 0 0 5 5
1863.7 8.80 6 0 0 0 0 0
1863.7 8.71 4 0 0 0 0 0
1783.7 7.30 6 7 18 36 0 0
1783.7 7.21 0 0 0 0
<1
0
1783.7 7.08 0 0 0 0 0
1701.6 7.91 5 0 0 0 0 0
1701.6 7.85 3 0 0 0 0 0
1662.6 6.18 0 0 0 0 14 14
1621.6 6.42 1 1 1 1 0
<1
1621.6 6.32 1 1 1 1 0
1605.6 5.97 0 0 0 0 0 0
1564.6 6.29 no 1 5 0 0 0
1539.5 7.18 4 0 0 0 0 0
1539.5 7.05 3 0 0 0 0 0
1459.5 5.50 0 0 0 0 37 37
1418.5 5.94 1 5 7 12 0 0
1377.5 6.18 3 0 0 0 0 0
1256.5 4.95 0 0 0 0 12 11
1256.5 5.07 0 3 3 3 0 0
1093.4 4.20 0 0 0 0 3 4
729.3 2.77 0 29 28 28 29 29
a m/z values are theoretical masses; observed values lie within +/- 0.75 Da range from this value (majority within +/- 0.3 Da).
b Exoglycosidase treatments are in sequence: A. Untreated, B. a-mannosidase, C. a-sialidase, D. a-fucosidase, E. b-galactosidase, 
F. a-galactosidase.
c nd = not determined. It should be noted that sialic acids are commonly lost prior to analysis by the MALDI-TOF-MS detector 
and are therefore not observed.
d Prior to treatment with a-mannosidase many of the minor components are not observed, due to overlap with the large oligoman-
nose-derived peaks. This is indicated by “no” for not observed. Since hybrid-type structures are not observed in column A, the 
presented percentages are based on column B data, resulting in a cumulative lower than 100% in column A.
Table S3.  N-Glycan structures observed in WFA-fraction II and after sequential exoglycosidase treatments. For each 
non-sialylated assigned NP-HPLC peak (percentages for each profile A-F are based on HPLC peak integrations), MALDI-
TOF-MS confirmation was acquireda.
Structure m/z GU Ab B C D E F
ndc 10.89 2 0 0 0 0 0
nd 10.42 2 0 0 0 0 0
nd 10.12 1 0 0 0 0 0
nd 9.82 4 0 0 0 0 0
nd 9.43 2 0 0 0 0 0
nd 9.38 4 0 0 0 0 0








15 0 0 0 0 0
nd 8.45 13 0 0 0 0 0
nd 7.99 14 0 0 0 0 0








8 0 0 0 0 0
nd 7.24 2 0 0 0 0 0
nd 6.83 4 0 0 0 0 0
2708.2 9.82 0 2 0 0 0 0
2562.1 9.55 0 2 0 0 0 0
2606.1 9.21 0 1 0 0 0 0




0 2 0 0 0 0
2628.2 8.72 0 4 0 0 0 0
2482.1 8.27 0 4 0 0 0 0




0 15 0 0 0 0




0 0 2 0 0 0




0 0 4 0 0 0
1767.7 ? 0 5 5 0 0 0
2011.8 7.33 0 14 14 0 0 0
1808.7 6.83 0 1 15 0 0 0
1605.6 6.16 0 2 1 0 0 0




0 0 2 3 0 0
2068.8 7.24 0 0 2 4 0 0
1865.7 7.05 0 0 4 8 0 0
1865.7 6.92 0 16 16 30 0 0
1783.7 7.04 0 2 2 4 0 0
1621.6 6.83 0 7 7 12 0 0
1662.6 6.08 2 2 19 34 0 0
1459.5 5.72 1 3 3 4 0 0
1580.6 6.72 0 0 0 0 4 0
1418.5 5.79 0 0 0 0 13 0
1459.5 5.58 0 0 0 0 80 79
1256.5 5.01 0 0 0 0 3 16
1093.4 4.22 0 0 0 0 0 5
a m/z values are theoretical masses, observed values lie within +/- 0.75 Da range from this value (majority within +/- 0.3 Da).
b Exoglycosidase treatments are in sequence: A. Untreated, B. a-sialidase, C. b-galactosidase, D. a-fucosidase, E. b-N-acetylhex-
osaminidase, F. a-mannosidase.
c nd = not determined. It should be noted that sialic acids are commonly lost prior to analysis by the MALDI-TOF-MS detector 
and are therefore not observed.
Table S4.  N-Glycan structures observed in WFA-fraction III and after sequential exoglycosidase treatments. For each as-
signed NP-HPLC peak (percentages for each profile A-E are based on peak integrations), MALDI-TOF-MS confirmation 
was acquireda.
Structure m/z GU Ab B C D E
2783.2 9.31 2 0 0 0 0
2637.1 8.99 1 1 0 0 0
2377.0 8.66 3 0 0 0 0
2418.0 8.32 3 0 0 0 0
2230.9 8.24 2 5 0 0 0
2271.9 8.01 3 6 0 0 0
1824.7 6.83 0 0 3 0 0
1970.7 7.61/7.56 4 0 0 0 0
2011.8 7.36 36 0 0 0 0
1824.7 7.17/7.10 4 8 0 0 0
1865.7 6.92 42 80 0 0 0
1621.6 6.49 0 0 5 0 0
1621.6 6.37 0 0 3 0 0
1662.6 6.06 0 0 0 3 0
1459.5 5.55 0 0 89 97 100
a m/z values are theoretical masses, observed values lie within +/- 0.75 Da range from this value (majority within +/- 0.3 Da).
b Exoglycosidase treatments are in sequence: A. Untreated, B. a-fucosidase, C. b-N-acetylhexosaminidase, D. b-galactosidase, E. 
b-N-acetylhexosaminidase.
Table S5.  O-glycan structures  observed in the O-glycan pool and after sequential exoglycosidase treatments. For each as-
signed NP-HPLC peak (percentages for each profile A-C are based on peak integrations), MALDI-TOF-MS confirmation 
was acquireda.
Structure m/z GU Ab B C
1070.4 4.46 54 0 0
1000.4 3.69 13 0 0
797.3 3.20 5 56 0
797.3 2.94 23 0 0
727.3 2.71 3 17 16
526.0 1.83 2 27 84
a m/z values are theoretical masses, observed values lie within +/- 0.75 Da range from this value (majority within +/- 0.3 Da).
b Exoglycosidase treatments are in sequence: A. Untreated, B. Salmonella typhimurium α-sialidase, C. Arthrobacter ureafaciens 
α-sialidase.


















Figure S1.  WAX-HPLC profiles of 2AB-labeled glycans in: A, N-glycan pool; B, WFA-fraction I; C, WFA-
fraction II; D, WFA-fraction III; and E, O-glycan pool. Peaks for neutral (N0 or O0), monocharged (N1 or 
O1), and dicharged (N2 or O2) are indicated in the chromatograms.
Figure S2.  Relevant parts of the one-dimensional 500-MHz 1H NMR spectrum of A. the O-glycan alditol 
pool, released from de-N-glycosylated bovine whey protein preparation by reductive alkaline treatment; B. 






Figure S3. HPAEC-PAD profile of the O-glycan alditol pool. Peaks 1 and 2 were isolated for 1H NMR  analysis, 
Peaks a – d were further analysed by MALDI-TOF-MS. Structures are presented in Scheme 5.
